Carfilzomib

Records for this ingredient, by country (identity only).

ATC L01XG02 · 12 markets · 40 records

Carfilzomib 12 markets · 40 records Forms
Filters
MarketES 9AU 7GB 4US 3CA 3TW 3FR 3SG 2HK 2JP 2CN 1EU 1

ES 9 records · 3 shown of 3 Source CIMA (AEMPS) · Data as of live

  • 30 mg per mL / per unit basis not statedinjectionKYPROLIS
  • 60 mg per mL / per unit basis not statedinjectionKYPROLIS
  • 10 mg per mL / per unit basis not statedinjectionKYPROLIS

AU 7 records · 3 shown of 3 Source TGA、PBS Schedule API v3 (Department of +1 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

  • 30 mg per mL / per unit basis not statedinjectionKYPROLISKYPROLIS carfilzomib 30 mg powder for injection vial unknown
  • 60 mg per mL / per unit basis not statedinjectionKYPROLISKYPROLIS carfilzomib 30 mg powder for injection vial unknown
  • 10 mg per mL / per unit basis not statedinjectionKYPROLISKYPROLIS carfilzomib 30 mg powder for injection vial unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名KYPROLIS ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

GB 4 records · 3 shown of 3 Source NHSBSA dm+d · Data as of 2026-10-19

US 3 records · 3 shown of 3 Source openFDA NDC Directory · Data as of 2026-10-23

CA 3 records · 3 shown of 3 Source Health Canada Drug Product Databas · Data as of 2026-10-23

TW 3 records · 1 shown of 1 Source 衛生福利部食品藥物管理署（TFDA）全部藥品許可證資料集 · Data as of 2026-10-22 · some records have no stated strength

  • 30 mg per mL / per unit basis not statedinjectionKyprolis forMyeloPro for Injection 30 mg、凱博斯凍晶注射劑30毫克、骨樂博凍晶注射劑30毫克
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Kyprolis for injection ×2凱博斯凍晶注射劑 ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

FR 3 records · 3 shown of 3 Source Base de données publique des médic · Data as of 2026-11-03

SG 2 records · 2 shown of 2 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

HK 2 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名KYPROLIS FOR INJECTION 30MG/VIAL ×4

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

JP 2 records · 2 shown of 2 Source 厚生労働省 薬価基準収載品目リスト · Data as of 2026-11-01

CN 1 records · 1 shown of 1 Source 国家医保局 医保药品分类与代码数据库 · Data as of 2025-04-04

  • 60 mg per mL / per unit basis not statedinjection凯洛斯卡非佐米

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名KYPROLIS ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.